Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Non-Current Deffered Revenue (2019 - 2025)

Historic Non-Current Deffered Revenue for Korro Bio (KRRO) over the last 4 years, with Q3 2025 value amounting to $4.8 million.

  • Korro Bio's Non-Current Deffered Revenue fell 3813.31% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 3813.31%. This contributed to the annual value of $5.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Korro Bio reported Non-Current Deffered Revenue of $4.8 million as of Q3 2025, which was down 3813.31% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Non-Current Deffered Revenue registered a high of $7.8 million during Q3 2024, and its lowest value of $4.5 million during Q2 2025.